Comprehensive suite of analytical techniques

To support biologics process development, Eurofins CDMO’s in-house R&D and GMP analytical teams provide a comprehensive suite of analytical techniques to ensure high quality and regulatory compliance.

adobestock_403448452

Advanced analytical techniques

Eurofins CDMO provides advanced analytical testing services to support biologics development, including in-process controls, batch release testing, stability studies, method validation, drug product characterisation, and lifecycle management of analytical methods, ensuring quality, compliance, and accelerated development.

Expand_img
  • In-process control (IPC) during development
  • Batch release testing
  • Stability and forced degradation studies
  • Photostability and material compatibility assessments
  • Identity verification and process residual analysis
  • Drug substance in process and release testing
  • GMP method validation
  • Lifecycle management of analytical methods
adobestock_281788371

R&D and GMP QC entities

Depending on the stage (process development versus GMP clinical batch manufacturing), Eurofins CDMO has an R&D analytical department as well as a GMP QC analytical department to support analytical requirements. At the appropriate moment and prior to GMP activities, the developed methods are pre-validated and transferred from the R&D environment to the GMP QC entity.

Expand_img

The R&D pre-validation intends to:

  • Demonstrate confidence in the methods for further usage in the R&D environment (e.g. for R&D accelerated stability studies)
  • De-risk and facilitate the transfer of methods from our R&D entity to our GMP QC entity for subsequent validation, release and stability testing activities in a GMP environment, ensuring timelines are met